1,720,990 research outputs found

    Co-soltrim (lidaprim): microbiological evaluation vs.co-trimoxazole

    No full text
    Cosoltrim (CTM) is the generic name suggested for the new combination of sulfametrole (SMT) (3-methoxy-44(4 amino-benzene-sulfonamide)-1,2,5-thiodazoleeee) with trimethoprim (TMP)in the 1:5 ratio (LIDAPRIM Farmades S.p.A. Roma, Italy). We have studied the antibacterial activity in vitro of SMT-CTM and of cotrimoxazole (CTZ) as a standard drug, on 99 strains of Gram-positive and Gram-negative bacteria which have been recently isolated from hospitalized patients.We also have carried out an in vivo study, by comparing the antibacterial activity(PD50) in mice of CMT with that of CTZ: In vitro, the CTM antibacterial activity appears slightly superior to that of CTZ on E. coli , and Propeus spp. and Providencia spp.:The study on the in vivo activity has been carried out by infecting mice with: Proteus mirabilis CH/1, Salmonella parathyphi.ASA12. The bacterial activity seems to be synergic for both application

    [Miocamycin: microbiological features].

    No full text
    Macrolides are antibiotics with high tolerability and wide activity spectrum both against Gram-positive and Gram-negative bacteria and other pathogenic agents: Miocamycin (MOM) belongs to this group. On this basis the antibacterial of the MOM has been proved on a sampling of hospital isolated staphylococci strains in comparison to josamicin and eriytromicin all belonging to the macrolides family and also to lincomycin and clindamicyn which have the same activity spectrum. Miocamycin compared to other antibiotics proved to be the most active against both methicillin-sensitive and methicillin-resistant strains

    ATTIVITA' ANTIBATTERICA ED ANTIFUNGINA DELLA PROPOLI

    No full text
    Samples of wax-removal propolis by a cold working and physic extractive method *E.P.I.D.® and crude propolis , were investigated for their antibacterial and fungicidal activity against clinical isolates Gram-positive strains and fungi. All the samples were active against tested microrganisms . E.P.I.D® propolis compared with crude propolis, shows a better antimicrobial activity against bacterial strains with MICs ranging from 0,156 to 1,25 mg/ml and fungi ranging from 0,6-5 mg/ml for Candida spp. and from 2,5-5 mg/ml against dermathophytes. Introduzione La propoli è una sostanza resinosa prodotta dalle api bottonatrici raccolta da diverse piante, da molto tempo conosciuta per le sue caratteristiche farmacologiche. Essa è raccolta dalle api in particolare dall’Apis mellifera, dai germogli, foglie e cortecce di differenti piante (betulle, pioppi, olmi etc.) , successivamente trasformata da enzimi presenti nella saliva. Viene utilizzata dalle api stesse per restringere l’ingresso dell’alveare, per chiudere le fessure presenti nell’arnia e per imbalsamare eventuali insetti predatori uccisi, dopo un’invasione dell’alveare. E’ usata come “medicamento alternativo”,in infezioni otorinolaringoiatriche, in odontoiatria, gastroenterologia, e in infezioni ginecologiche. Le proprietà antibatteriche e antifungine della propoli sono note, ma la sua efficacia è correlata all’origine geografica, a causa della diversa composizione chimica dovuta alle diverse piante. (2) Tra i vari costituenti: cere, resine, balsami, olii essenziali, acidi aromatici, polline e costituenti polifenolici con predominanza di composti a struttura flavonoide, aldeidi, acido benzoico e caffeico sono le più importanti sostanze riscontrate nella composizione della propoli, la loro quantità è dipendente dal luogo e dal tempo di raccolta. Sono sta

    Multifactorial aspects of antimicrobial activity of propolis

    No full text
    We investigated the antibacterial activity of sub-inhibitory concentrations of ethanolic extract of propolis (EEP), and its effect on the antibacterial activity of some antibiotics. Some clinically isolated Gram-positive strains were used. Moreover, sub-inhibitory concentrations of EEP were used to value its action on some important virulence factors like lipase and coagulase enzymes, and on biofilm formation in Staphylococcus aureus. Our results indicated that EEP had a significant antimicrobial activity towards all tested clinical strains. Adding EEP to antibacterial tested drugs, it drastically increased the antimicrobial effect of ampicillin, gentamycin and streptomycin, moderately the one of chloramphenicol, ceftriaxon and vancomycin, while there was no effect with erithromycin. Moreover, our results pointed out an inhibitory action of EEP on tipase activity of 18 Staphytococcus spp. strains and an inhibitory effect on coagulase of 11 S. aureus tested strains. The same EEP concentrations showed a negative interaction with adhesion and consequent biofilm formation in S. aureus ATCC 6538P. (c) 2006 Elsevier GmbH. All rights reserved
    corecore